Global Hospital Injectable Drugs Market Insights and Forecast to 2028

Report ID: 1242215 | Published Date: Jan 2025 | No. of Page: 126 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Generic Sterile Injectables
        1.2.3 Sterile Intravenous (IV) Solutions
    1.3 Market by Application
        1.3.1 Global Hospital Injectable Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Anesthesia
        1.3.4 Anti-Infectives
        1.3.5 Parenteral Nutrition
        1.3.6 Cardiovascular Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hospital Injectable Drugs Market Perspective (2017-2028)
    2.2 Hospital Injectable Drugs Growth Trends by Region
        2.2.1 Hospital Injectable Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hospital Injectable Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Hospital Injectable Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Hospital Injectable Drugs Market Dynamics
        2.3.1 Hospital Injectable Drugs Industry Trends
        2.3.2 Hospital Injectable Drugs Market Drivers
        2.3.3 Hospital Injectable Drugs Market Challenges
        2.3.4 Hospital Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hospital Injectable Drugs Players by Revenue
        3.1.1 Global Top Hospital Injectable Drugs Players by Revenue (2017-2022)
        3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hospital Injectable Drugs Revenue
    3.4 Global Hospital Injectable Drugs Market Concentration Ratio
        3.4.1 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2021
    3.5 Hospital Injectable Drugs Key Players Head office and Area Served
    3.6 Key Players Hospital Injectable Drugs Product Solution and Service
    3.7 Date of Enter into Hospital Injectable Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Injectable Drugs Breakdown Data by Type
    4.1 Global Hospital Injectable Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Hospital Injectable Drugs Forecasted Market Size by Type (2023-2028)
5 Hospital Injectable Drugs Breakdown Data by Application
    5.1 Global Hospital Injectable Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Hospital Injectable Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hospital Injectable Drugs Market Size (2017-2028)
    6.2 North America Hospital Injectable Drugs Market Size by Type
        6.2.1 North America Hospital Injectable Drugs Market Size by Type (2017-2022)
        6.2.2 North America Hospital Injectable Drugs Market Size by Type (2023-2028)
        6.2.3 North America Hospital Injectable Drugs Market Share by Type (2017-2028)
    6.3 North America Hospital Injectable Drugs Market Size by Application
        6.3.1 North America Hospital Injectable Drugs Market Size by Application (2017-2022)
        6.3.2 North America Hospital Injectable Drugs Market Size by Application (2023-2028)
        6.3.3 North America Hospital Injectable Drugs Market Share by Application (2017-2028)
    6.4 North America Hospital Injectable Drugs Market Size by Country
        6.4.1 North America Hospital Injectable Drugs Market Size by Country (2017-2022)
        6.4.2 North America Hospital Injectable Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Hospital Injectable Drugs Market Size (2017-2028)
    7.2 Europe Hospital Injectable Drugs Market Size by Type
        7.2.1 Europe Hospital Injectable Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Hospital Injectable Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Hospital Injectable Drugs Market Share by Type (2017-2028)
    7.3 Europe Hospital Injectable Drugs Market Size by Application
        7.3.1 Europe Hospital Injectable Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Hospital Injectable Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Hospital Injectable Drugs Market Share by Application (2017-2028)
    7.4 Europe Hospital Injectable Drugs Market Size by Country
        7.4.1 Europe Hospital Injectable Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Hospital Injectable Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hospital Injectable Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type
        8.2.1 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Hospital Injectable Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Application
        8.3.1 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Hospital Injectable Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Hospital Injectable Drugs Market Size by Region
        8.4.1 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Hospital Injectable Drugs Market Size (2017-2028)
    9.2 Latin America Hospital Injectable Drugs Market Size by Type
        9.2.1 Latin America Hospital Injectable Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Hospital Injectable Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Hospital Injectable Drugs Market Share by Type (2017-2028)
    9.3 Latin America Hospital Injectable Drugs Market Size by Application
        9.3.1 Latin America Hospital Injectable Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Hospital Injectable Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Hospital Injectable Drugs Market Share by Application (2017-2028)
    9.4 Latin America Hospital Injectable Drugs Market Size by Country
        9.4.1 Latin America Hospital Injectable Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Hospital Injectable Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hospital Injectable Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type
        10.2.1 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Hospital Injectable Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application
        10.3.1 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Hospital Injectable Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Hospital Injectable Drugs Market Size by Country
        10.4.1 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Hospira (Pfizer Inc.)
        11.1.1 Hospira (Pfizer Inc.) Company Details
        11.1.2 Hospira (Pfizer Inc.) Business Overview
        11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Introduction
        11.1.4 Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.1.5 Hospira (Pfizer Inc.) Recent Developments
    11.2 Baxter
        11.2.1 Baxter Company Details
        11.2.2 Baxter Business Overview
        11.2.3 Baxter Hospital Injectable Drugs Introduction
        11.2.4 Baxter Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.2.5 Baxter Recent Developments
    11.3 Fresenius Kabi
        11.3.1 Fresenius Kabi Company Details
        11.3.2 Fresenius Kabi Business Overview
        11.3.3 Fresenius Kabi Hospital Injectable Drugs Introduction
        11.3.4 Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.3.5 Fresenius Kabi Recent Developments
    11.4 Sandoz (Novartis)
        11.4.1 Sandoz (Novartis) Company Details
        11.4.2 Sandoz (Novartis) Business Overview
        11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Introduction
        11.4.4 Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.4.5 Sandoz (Novartis) Recent Developments
    11.5 Hikma Pharmaceuticals PLC
        11.5.1 Hikma Pharmaceuticals PLC Company Details
        11.5.2 Hikma Pharmaceuticals PLC Business Overview
        11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Introduction
        11.5.4 Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.5.5 Hikma Pharmaceuticals PLC Recent Developments
    11.6 Dr. Reddy’s Laboratories Ltd
        11.6.1 Dr. Reddy’s Laboratories Ltd Company Details
        11.6.2 Dr. Reddy’s Laboratories Ltd Business Overview
        11.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Introduction
        11.6.4 Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.6.5 Dr. Reddy’s Laboratories Ltd Recent Developments
    11.7 Grifols
        11.7.1 Grifols Company Details
        11.7.2 Grifols Business Overview
        11.7.3 Grifols Hospital Injectable Drugs Introduction
        11.7.4 Grifols Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.7.5 Grifols Recent Developments
    11.8 Nichi-Iko Group (Sagent)
        11.8.1 Nichi-Iko Group (Sagent) Company Details
        11.8.2 Nichi-Iko Group (Sagent) Business Overview
        11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Introduction
        11.8.4 Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.8.5 Nichi-Iko Group (Sagent) Recent Developments
    11.9 Teva Pharmaceutical
        11.9.1 Teva Pharmaceutical Company Details
        11.9.2 Teva Pharmaceutical Business Overview
        11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Introduction
        11.9.4 Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.9.5 Teva Pharmaceutical Recent Developments
    11.10 Otsuka
        11.10.1 Otsuka Company Details
        11.10.2 Otsuka Business Overview
        11.10.3 Otsuka Hospital Injectable Drugs Introduction
        11.10.4 Otsuka Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.10.5 Otsuka Recent Developments
    11.11 B.Braun
        11.11.1 B.Braun Company Details
        11.11.2 B.Braun Business Overview
        11.11.3 B.Braun Hospital Injectable Drugs Introduction
        11.11.4 B.Braun Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.11.5 B.Braun Recent Developments
    11.12 JW Life Science
        11.12.1 JW Life Science Company Details
        11.12.2 JW Life Science Business Overview
        11.12.3 JW Life Science Hospital Injectable Drugs Introduction
        11.12.4 JW Life Science Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.12.5 JW Life Science Recent Developments
    11.13 Auromedics
        11.13.1 Auromedics Company Details
        11.13.2 Auromedics Business Overview
        11.13.3 Auromedics Hospital Injectable Drugs Introduction
        11.13.4 Auromedics Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.13.5 Auromedics Recent Developments
    11.14 Sanofi
        11.14.1 Sanofi Company Details
        11.14.2 Sanofi Business Overview
        11.14.3 Sanofi Hospital Injectable Drugs Introduction
        11.14.4 Sanofi Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.14.5 Sanofi Recent Developments
    11.15 Gland Pharma
        11.15.1 Gland Pharma Company Details
        11.15.2 Gland Pharma Business Overview
        11.15.3 Gland Pharma Hospital Injectable Drugs Introduction
        11.15.4 Gland Pharma Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.15.5 Gland Pharma Recent Developments
    11.16 Endo International PLC
        11.16.1 Endo International PLC Company Details
        11.16.2 Endo International PLC Business Overview
        11.16.3 Endo International PLC Hospital Injectable Drugs Introduction
        11.16.4 Endo International PLC Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.16.5 Endo International PLC Recent Developments
    11.17 Sichuan Kelun Pharmaceutical
        11.17.1 Sichuan Kelun Pharmaceutical Company Details
        11.17.2 Sichuan Kelun Pharmaceutical Business Overview
        11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Introduction
        11.17.4 Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.17.5 Sichuan Kelun Pharmaceutical Recent Developments
    11.18 Cisen Pharmaceutical
        11.18.1 Cisen Pharmaceutical Company Details
        11.18.2 Cisen Pharmaceutical Business Overview
        11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Introduction
        11.18.4 Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.18.5 Cisen Pharmaceutical Recent Developments
    11.19 Shijiazhuang No. 4 Pharmaceutical
        11.19.1 Shijiazhuang No. 4 Pharmaceutical Company Details
        11.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
        11.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Introduction
        11.19.4 Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments
    11.20 Shandong Hualu Pharmaceutical
        11.20.1 Shandong Hualu Pharmaceutical Company Details
        11.20.2 Shandong Hualu Pharmaceutical Business Overview
        11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Introduction
        11.20.4 Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.20.5 Shandong Hualu Pharmaceutical Recent Developments
    11.21 CR Double-Crane
        11.21.1 CR Double-Crane Company Details
        11.21.2 CR Double-Crane Business Overview
        11.21.3 CR Double-Crane Hospital Injectable Drugs Introduction
        11.21.4 CR Double-Crane Revenue in Hospital Injectable Drugs Business (2017-2022)
        11.21.5 CR Double-Crane Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Hospital Injectable Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Generic Sterile Injectables
    Table 3. Key Players of Sterile Intravenous (IV) Solutions
    Table 4. Global Hospital Injectable Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Hospital Injectable Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hospital Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hospital Injectable Drugs Market Share by Region (2017-2022)
    Table 8. Global Hospital Injectable Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hospital Injectable Drugs Market Share by Region (2023-2028)
    Table 10. Hospital Injectable Drugs Market Trends
    Table 11. Hospital Injectable Drugs Market Drivers
    Table 12. Hospital Injectable Drugs Market Challenges
    Table 13. Hospital Injectable Drugs Market Restraints
    Table 14. Global Hospital Injectable Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hospital Injectable Drugs Revenue Share by Players (2017-2022)
    Table 16. Global Top Hospital Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2021)
    Table 17. Ranking of Global Top Hospital Injectable Drugs Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hospital Injectable Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hospital Injectable Drugs Product Solution and Service
    Table 21. Date of Enter into Hospital Injectable Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hospital Injectable Drugs Revenue Market Share by Type (2017-2022)
    Table 25. Global Hospital Injectable Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hospital Injectable Drugs Revenue Market Share by Type (2023-2028)
    Table 27. Global Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hospital Injectable Drugs Revenue Share by Application (2017-2022)
    Table 29. Global Hospital Injectable Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hospital Injectable Drugs Revenue Share by Application (2023-2028)
    Table 31. North America Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Hospital Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Hospital Injectable Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Hospital Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Hospital Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Hospital Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Hospital Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Hospital Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Hospital Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Hospira (Pfizer Inc.) Company Details
    Table 62. Hospira (Pfizer Inc.) Business Overview
    Table 63. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product
    Table 64. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 65. Hospira (Pfizer Inc.) Recent Developments
    Table 66. Baxter Company Details
    Table 67. Baxter Business Overview
    Table 68. Baxter Hospital Injectable Drugs Product
    Table 69. Baxter Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 70. Baxter Recent Developments
    Table 71. Fresenius Kabi Company Details
    Table 72. Fresenius Kabi Business Overview
    Table 73. Fresenius Kabi Hospital Injectable Drugs Product
    Table 74. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 75. Fresenius Kabi Recent Developments
    Table 76. Sandoz (Novartis) Company Details
    Table 77. Sandoz (Novartis) Business Overview
    Table 78. Sandoz (Novartis) Hospital Injectable Drugs Product
    Table 79. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 80. Sandoz (Novartis) Recent Developments
    Table 81. Hikma Pharmaceuticals PLC Company Details
    Table 82. Hikma Pharmaceuticals PLC Business Overview
    Table 83. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product
    Table 84. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 85. Hikma Pharmaceuticals PLC Recent Developments
    Table 86. Dr. Reddy’s Laboratories Ltd Company Details
    Table 87. Dr. Reddy’s Laboratories Ltd Business Overview
    Table 88. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product
    Table 89. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 90. Dr. Reddy’s Laboratories Ltd Recent Developments
    Table 91. Grifols Company Details
    Table 92. Grifols Business Overview
    Table 93. Grifols Hospital Injectable Drugs Product
    Table 94. Grifols Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 95. Grifols Recent Developments
    Table 96. Nichi-Iko Group (Sagent) Company Details
    Table 97. Nichi-Iko Group (Sagent) Business Overview
    Table 98. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product
    Table 99. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 100. Nichi-Iko Group (Sagent) Recent Developments
    Table 101. Teva Pharmaceutical Company Details
    Table 102. Teva Pharmaceutical Business Overview
    Table 103. Teva Pharmaceutical Hospital Injectable Drugs Product
    Table 104. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 105. Teva Pharmaceutical Recent Developments
    Table 106. Otsuka Company Details
    Table 107. Otsuka Business Overview
    Table 108. Otsuka Hospital Injectable Drugs Product
    Table 109. Otsuka Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 110. Otsuka Recent Developments
    Table 111. B.Braun Company Details
    Table 112. B.Braun Business Overview
    Table 113. B.Braun Hospital Injectable Drugs Product
    Table 114. B.Braun Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 115. B.Braun Recent Developments
    Table 116. JW Life Science Company Details
    Table 117. JW Life Science Business Overview
    Table 118. JW Life Science Hospital Injectable Drugs Product
    Table 119. JW Life Science Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 120. JW Life Science Recent Developments
    Table 121. Auromedics Company Details
    Table 122. Auromedics Business Overview
    Table 123. Auromedics Hospital Injectable Drugs Product
    Table 124. Auromedics Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 125. Auromedics Recent Developments
    Table 126. Sanofi Company Details
    Table 127. Sanofi Business Overview
    Table 128. Sanofi Hospital Injectable Drugs Product
    Table 129. Sanofi Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 130. Sanofi Recent Developments
    Table 131. Gland Pharma Company Details
    Table 132. Gland Pharma Business Overview
    Table 133. Gland Pharma Hospital Injectable Drugs Product
    Table 134. Gland Pharma Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 135. Gland Pharma Recent Developments
    Table 136. Endo International PLC Company Details
    Table 137. Endo International PLC Business Overview
    Table 138. Endo International PLC Hospital Injectable Drugs Product
    Table 139. Endo International PLC Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 140. Endo International PLC Recent Developments
    Table 141. Sichuan Kelun Pharmaceutical Company Details
    Table 142. Sichuan Kelun Pharmaceutical Business Overview
    Table 143. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product
    Table 144. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 145. Sichuan Kelun Pharmaceutical Recent Developments
    Table 146. Cisen Pharmaceutical Company Details
    Table 147. Cisen Pharmaceutical Business Overview
    Table 148. Cisen Pharmaceutical Hospital Injectable Drugs Product
    Table 149. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 150. Cisen Pharmaceutical Recent Developments
    Table 151. Shijiazhuang No. 4 Pharmaceutical Company Details
    Table 152. Shijiazhuang No. 4 Pharmaceutical Business Overview
    Table 153. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product
    Table 154. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 155. Shijiazhuang No. 4 Pharmaceutical Recent Developments
    Table 156. Shandong Hualu Pharmaceutical Company Details
    Table 157. Shandong Hualu Pharmaceutical Business Overview
    Table 158. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product
    Table 159. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 160. Shandong Hualu Pharmaceutical Recent Developments
    Table 161. CR Double-Crane Company Details
    Table 162. CR Double-Crane Business Overview
    Table 163. CR Double-Crane Hospital Injectable Drugs Product
    Table 164. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2017-2022) & (US$ Million)
    Table 165. CR Double-Crane Recent Developments
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hospital Injectable Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Generic Sterile Injectables Features
    Figure 3. Sterile Intravenous (IV) Solutions Features
    Figure 4. Global Hospital Injectable Drugs Market Share by Application: 2021 VS 2028
    Figure 5. Oncology Case Studies
    Figure 6. Anesthesia Case Studies
    Figure 7. Anti-Infectives Case Studies
    Figure 8. Parenteral Nutrition Case Studies
    Figure 9. Cardiovascular Diseases Case Studies
    Figure 10. Hospital Injectable Drugs Report Years Considered
    Figure 11. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Hospital Injectable Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Hospital Injectable Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Hospital Injectable Drugs Market Share by Players in 2021
    Figure 15. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2021
    Figure 17. North America Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
    Figure 19. North America Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
    Figure 20. North America Hospital Injectable Drugs Market Size Share by Country (2017-2028)
    Figure 21. United States Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Hospital Injectable Drugs Market Size Share by Country (2017-2028)
    Figure 27. Germany Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Hospital Injectable Drugs Market Size Share by Region (2017-2028)
    Figure 37. China Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Hospital Injectable Drugs Market Size Share by Country (2017-2028)
    Figure 47. Mexico Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Hospital Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Hospital Injectable Drugs Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Hospital Injectable Drugs Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Hospital Injectable Drugs Market Size Share by Country (2017-2028)
    Figure 53. Turkey Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Hospital Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 57. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 58. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 59. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 60. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 61. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 62. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 63. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 64. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 65. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 66. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 67. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 68. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 69. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 70. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 71. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 72. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 73. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 74. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 75. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 76. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Frequently Asked Questions
Hospital Injectable Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hospital Injectable Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hospital Injectable Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Generic Injectables

Generic Injectables market is segmented by players, region (country), by Type and by Application. ... Read More